MC
Maverick Capital Portfolio holdings
AUM
$6.51B
1-Year Return
55.18%
This Quarter Return
-2.86%
1 Year Return
+55.18%
3 Year Return
+222.76%
5 Year Return
+121.04%
10 Year Return
+278.16%
AUM
$10.6B
AUM Growth
-$43.6M
(-0.41%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.94%
Top 10 Holdings %
Top 10 Hldgs %
60.2%
Holding
912
New
227
Increased
218
Reduced
209
Closed
252
Top Buys
| 1 |
Centene
CNC
|
+$249M |
| 2 |
Jones Lang LaSalle
JLL
|
+$172M |
| 3 |
CANO
Cano Health, Inc.
CANO
|
+$96M |
| 4 |
Carvana
CVNA
|
+$94M |
| 5 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$65.4M |
Top Sells
| 1 |
Applied Materials
AMAT
|
+$95.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$85.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$77.1M |
| 4 |
Lam Research
LRCX
|
+$75.3M |
| 5 |
Amazon
AMZN
|
+$74.1M |
Sector Composition
| 1 | Consumer Discretionary | 52.87% |
| 2 | Healthcare | 14.71% |
| 3 | Technology | 11.2% |
| 4 | Communication Services | 7.76% |
| 5 | Financials | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
BioMarin Pharmaceuticals
BMRN
$10.5B
| $541K | 0.01% |
+6,480
| New | +$541K |
|
377
Truist Financial
TFC
$58.3B
| $541K | 0.01% |
+9,744
| New | +$541K |
|
378
Dolby
DLB
$6.81B
| $539K | 0.01% |
5,485
+461
| +9% | +$45.3K |
|
379
Alkermes
ALKS
$4.44B
| $535K | 0.01% |
21,836
-10,222
| -32% | -$250K |
|
380
Western Digital
WDC
$32.7B
| $534K | 0.01% |
+9,924
| New | +$534K |
|
381
Intuitive Surgical
ISRG
$162B
| $533K | 0.01% |
1,740
-10,746
| -86% | -$3.29M |
|
382
IPG Photonics
IPGP
$3.47B
| $528K | 0.01% |
2,505
-1,257
| -33% | -$265K |
|
383
Keysight
KEYS
$29.2B
| $526K | ﹤0.01% |
3,408
-1,552
| -31% | -$240K |
|
384
Revvity
RVTY
$9.75B
| $522K | ﹤0.01% |
+3,381
| New | +$522K |
|
385
Stryker
SYK
$146B
| $516K | ﹤0.01% |
1,987
-6,043
| -75% | -$1.57M |
|
386
Chegg
CHGG
$175M
| $511K | ﹤0.01% |
+6,143
| New | +$511K |
|
387
Fox Class A
FOXA
$25.1B
| $511K | ﹤0.01% |
13,755
-1,206
| -8% | -$44.8K |
|
388
Pinterest
PINS
$24B
| $502K | ﹤0.01% |
+6,353
| New | +$502K |
|
|
AYX
389
DELISTED
Alteryx, Inc.
AYX
| $501K | ﹤0.01% |
+5,819
| New | +$501K |
|
390
MetLife
MET
$52.7B
| $496K | ﹤0.01% |
+8,289
| New | +$496K |
|
391
Medifast
MED
$150M
| $495K | ﹤0.01% |
1,750
-3,490
| -67% | -$987K |
|
392
IDEX
IEX
$12.1B
| $478K | ﹤0.01% |
+2,172
| New | +$478K |
|
393
Guess, Inc.
GES
$868M
| $470K | ﹤0.01% |
17,817
-40,350
| -69% | -$1.06M |
|
|
CSII
394
DELISTED
Cardiovascular Systems, Inc.
CSII
| $457K | ﹤0.01% |
+10,716
| New | +$457K |
|
|
BHVN
395
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $446K | ﹤0.01% |
+4,594
| New | +$446K |
|
396
Teva Pharmaceuticals
TEVA
$22.6B
| $444K | ﹤0.01% |
44,879
-110,962
| -71% | -$1.1M |
|
397
Thermo Fisher Scientific
TMO
$182B
| $442K | ﹤0.01% |
876
-1,519
| -63% | -$766K |
|
398
KALA BIO
KALA
$105M
| $433K | ﹤0.01% |
+1,635
| New | +$433K |
|
399
Cheniere Energy
LNG
$51.8B
| $430K | ﹤0.01% |
4,961
+4,011
| +422% | +$348K |
|
400
Merck
MRK
$210B
| $426K | ﹤0.01% |
5,480
-28,418
| -84% | -$2.21M |
|